Keywords: |
cancer chemotherapy; cancer survival; treatment outcome; survival analysis; cancer surgery; surgical technique; survival rate; disease course; cisplatin; cancer growth; cancer radiotherapy; chemotherapy, adjuvant; combined modality therapy; radiotherapy, adjuvant; cancer staging; neoplasm staging; treatment indication; imatinib; metastasis; computer assisted tomography; etoposide; thoracotomy; editorial; risk assessment; disease severity; cyclooxygenase 2; remission induction; neoplasm invasiveness; upregulation; thymoma; thymectomy; thymus neoplasms; review literature as topic
|